A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India
A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India
Not yet recruiting · NCT07822880 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India | Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, thyroid gland disorder, thyroid tumor | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07822880 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aadhar Health Institute | Hisar | India | 1 |
| AIIMS, Bhubaneshwar | Bhubaneswar | India | 2 |
| Government Medical College, Kozhikode | Kozhikode | India | 2 |
| Institute Rotary Cancer Hospital | New Delhi | India | 1 |
| MPMMCC(Mahamana Cancer Hospital) | Varanasi | India | 1 |
| Mumbai Oncocare Center | Mumbai (E) | India | 1 |
| Ruby General Hospital Pvt. Ltd | Kolkata | India | 1 |
| SRV Hospitals | Bengaluru | India | 2 |
| The Gujarat Cancer & Research Institute (GCRI) | Ahmedabad | India | 1 |
| Vardhman Mahavir Medical College & Safdarjung Hospital | New Delhi | India | 1 |